RECRUITINGOBSERVATIONAL

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

About This Trial

This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).

Who May Be Eligible (Plain English)

Who May Qualify: - Reside within the 50 states of the United States at the time of enrollment - Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state - Active email account - Fluency in English (spoken / written), as demonstrated by the ability to read and sign the willing to sign a consent form Form Who Should NOT Join This Trial: - Live in an overseas territory of the United States - Inability or unwillingness to provide written willing to sign a consent form - Diagnosed myasthenia gravis, including sero-negative MG\* - Diagnosed multiple sclerosis - Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Reside within the 50 states of the United States at the time of enrollment * Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state * Active email account * Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form Exclusion Criteria: * Live in an overseas territory of the United States * Inability or unwillingness to provide written informed consent * Diagnosed myasthenia gravis, including sero-negative MG\* * Diagnosed multiple sclerosis * Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke

Treatments Being Tested

BEHAVIORAL

Social media recruitment

Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment

BEHAVIORAL

Self-Assessment

Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups

BEHAVIORAL

Follow-up

Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis

Locations (1)

ZS Associates

Evanston, Illinois, United States